NASDAQ · Financial Statements

Astrana Health Inc. (ASTH) Financial Statements

$37.45 NASDAQ: ASTH Market Cap $1.86B

Astrana Health Inc. most recently reported annual revenue of $3.2B, net profit of $22.0M. Revenue grew at an average annual rate of 53.8% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Astrana Health Inc.: Revenue rose from $44.0M in 2015 to $3.2B in 2025, a change of +7131.8% over 9 years; net profit was positive in 8 of 10 reported years; operating margin moved from -14.9% to 2.5%, a shift of +17.4 percentage points; the most recent year shows net profit of $22.0M.

Income Statement — 10 Years (USD millions)

Metric2015201720182019202020212022202320242025
Revenue$44.0M$358.0M$520.0M$561.0M$370.0M$774.0M$1.1B$1.4B$2.0B$3.2B
Operating Expenses$51.0M$320.0M$428.0M$528.0M$364.0M$676.0M$1.0B$1.3B$1.9B$3.1B
Operating Profit$-7.0M$38.0M$92.0M$32.0M$6.0M$98.0M$104.0M$85.0M$89.0M$79.0M
Operating Margin-14.9%10.5%17.7%5.8%1.6%12.7%9.1%6.1%4.4%2.5%
Other Income$-2.0M$12.0M$-10.0M$-7.0M$3.0M$-20.0M$-18.0M$5.0M$-9.0M$-39.0M
Interest$1.0M$0$1.0M$5.0M$3.0M$5.0M$8.0M$16.0M$33.0M$50.0M
Depreciation$0$19.0M$19.0M$18.0M$18.0M$18.0M$18.0M$18.0M$28.0M$46.0M
Profit Before Tax$-8.0M$50.0M$83.0M$26.0M$9.0M$78.0M$87.0M$90.0M$81.0M$40.0M
Tax$860,000$7.8M$27.1M$31.6M$103.5M$40.8M$47.2M$35.6M$38.2M$39.2M
Net Profit$-9.0M$26.0M$11.0M$14.0M$-24.0M$69.0M$45.0M$61.0M$43.0M$22.0M
EPS$-1.79$0.90$0.29$0.39$1.01$1.52$0.99$1.29$0.90$0.46
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$348.0M$353.0M$404.0M$486.0M$479.0M$665.0M$620.0M$655.0M$956.0M$951.0M$965.0M$973.0M
Operating Expenses$309.0M$357.0M$374.0M$456.0M$450.0M$664.0M$600.0M$634.0M$937.0M$932.0M$937.0M$938.0M
Operating Profit$39.0M$-4.0M$30.0M$30.0M$28.0M$1.0M$21.0M$20.0M$19.0M$18.0M$29.0M$34.0M
Operating Margin11.2%-1.1%7.5%6.2%5.9%0.1%3.3%3.1%2.0%1.9%3.0%3.5%
Interest$4.0M$5.0M$8.0M$9.0M$9.0M$8.0M$7.0M$7.0M$18.0M$18.0M$16.0M$16.0M
Profit Before Tax$38.0M$1.0M$24.0M$32.0M$27.0M$-2.0M$10.0M$17.0M$6.0M$8.0M$20.0M$27.0M
Tax$26.4M$110.2M$29.8M$31.4M$29.2M$-310.4M$35.2M$39.3M$81.0M$12.6M$33.4M$32.2M
Net Profit$22.0M$12.0M$15.0M$19.0M$16.0M$-7.0M$7.0M$9.0M$0$6.0M$14.0M$20.0M
EPS$0.47$0.26$0.31$0.40$0.33$-0.14$0.14$0.19$0.01$0.12$0.29$0.40

Over the 10 years reported for Astrana Health Inc., cash stood at $429.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 1.40 times.

Balance Sheet — 10 Years (USD millions)

Metric2015201720182019202020212022202320242025
Total Assets$20.0M$491.0M$513.0M$729.0M$817.0M$867.0M$966.0M$933.0M$1.4B$2.2B
Current Assets$14.0M$144.0M$173.0M$329.0M$339.0M$404.0M$428.0M$462.0M$638.0M$863.0M
Cash$9.0M$120.0M$107.0M$103.0M$193.0M$233.0M$288.0M$294.0M$288.0M$429.0M
Inventory$0$0$0$0$0$0$0$0$0$0
Receivables$4.0M$20.0M$57.0M$99.0M$61.0M$99.0M$120.0M$148.0M$325.0M$408.0M
Fixed Assets$1.0M$14.0M$13.0M$26.0M$48.0M$69.0M$129.0M$45.0M$47.0M$94.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$1.0M$39.0M$55.0M$146.0M$148.0M$96.0M$48.0M$35.0M$51.0M$26.0M
Other Assets$2.0M$190.0M$186.0M$239.0M$239.0M$246.0M$269.0M$279.0M$419.0M$864.0M
Total Liabilities$11.0M$154.0M$106.0M$368.0M$372.0M$357.0M$408.0M$523.0M$841.0M$1.7B
Current Liabilities$7.0M$110.0M$72.0M$105.0M$115.0M$115.0M$149.0M$219.0M$366.0M$615.0M
Borrowings$0$6.0M$14.0M$257.0M$261.0M$201.0M$229.0M$321.0M$472.0M$1.1B
Other Liabilities$11.0M$148.0M$93.0M$111.0M$112.0M$156.0M$178.0M$202.0M$369.0M$582.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$6.0M$160.0M$181.0M$192.0M$331.0M$448.0M$543.0M$614.0M$713.0M$779.0M

For Astrana Health Inc., operating cash flow was positive in 9 of 10 reported years; free cash flow in the latest year was $104.0M; free cash flow was positive in 9 of 10 years; financing activities used $28.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2015201720182019202020212022202320242025
Operating Cash Flow$-2.0M$53.0M$26.0M$14.0M$46.0M$70.0M$82.0M$68.0M$52.0M$115.0M
Investing Cash Flow$-1.0M$5.0M$-27.0M$-182.0M$94.0M$-3.0M$-30.0M$-94.0M$-200.0M$-549.0M
Financing Cash Flow$-1.0M$-12.0M$-5.0M$-10.0M$-2.0M$-7.0M$-5.0M$-15.0M$-14.0M$-28.0M
Net Cash Flow$4.0M$111.0M$-13.0M$-4.0M$90.0M$39.0M$55.0M$6.0M$-5.0M$145.0M
Free Cash Flow$-2.0M$51.0M$25.0M$13.0M$45.0M$51.0M$59.0M$40.0M$44.0M$104.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.76
EV / EBITDA13.39
FCF Yield8.98%
Quick Ratio1.23
Interest Coverage1.49
Return 1Y82.67%
Return 3Y21.67%
Return 5Y-62.83%

Astrana Health Inc. (ASTH) financials — frequently asked questions

What is Astrana Health Inc.'s annual revenue?

Astrana Health Inc. (ASTH) reported annual revenue of $3.2B in its most recent fiscal year.

What is Astrana Health Inc.'s net profit?

Astrana Health Inc. (ASTH) reported net profit of $22.0M in its most recent fiscal year.

What is ASTH EV/EBITDA?

Astrana Health Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 13.39.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
ASTH Overview ASTH Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.